Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunosuppression after pediatric liver transplantation may lead to early and prolonged acute thymic involution: findings from a pilot longitudinal study.

Frontiers in immunology·2026
Same author

Extracellular matrix mediated neuroendocrine control of the thymus.

Neuroimmunomodulation·2026
Same author

GM-CSF Promotes Superior In Vitro Differentiation of MHC II<sup>+</sup> CD11c<sup>+</sup> APCs Compared to L-929 Supernatant in Mouse Bone Marrow Cultures.

International journal of molecular sciences·2026
Same author

Platelet activation and platelet-monocyte interaction amplify thromboinflammation in obesity through adhesion molecules and endothelial IL-1R signaling.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Zika virus infection disturbs development of human muscle progenitor cells.

Frontiers in cellular and infection microbiology·2026
Same author

Human Laminin-111-Derived AG73 Increases Proliferation, Migration, and Differentiation of Human Myoblasts: A Promising Candidate in Regenerative Medicine.

ACS omega·2026

Related Experiment Video

Updated: Jun 15, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Thymic microenvironmental alterations in experimentally induced diabetes.

Patrícia R A Nagib1, Jacy Gameiro, Luiz Guilherme Stivanin-Silva

  • 1Department of Anatomy, Cell Biology and Physiology, Institute of Biology, State University of Campinas-UNICAMP, Campinas, São Paulo, Brazil.

Immunobiology
|March 2, 2010
PubMed
Summary

Diabetes significantly alters the thymus microenvironment, impacting T cell development. Researchers observed thymic atrophy and changes in key proteins and chemokines, affecting T cell maturation in diabetic mice.

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jun 15, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Diabetes mellitus is associated with endocrine changes that can affect immune function.
  • The thymus is crucial for T cell development and maturation, requiring a specific microenvironment.
  • The immunologic consequences of diabetes on the thymus remain poorly understood.

Purpose of the Study:

  • To investigate the immunologic consequences of diabetes on the thymic microenvironment.
  • To examine alterations in thymocyte subpopulations and extracellular matrix components in diabetic mice.
  • To evaluate the expression of key chemokines and their receptors within the diabetic thymus.

Main Methods:

  • Histological analysis of thymic tissue from alloxan-diabetic and control mice.
  • Immunohistochemistry to assess laminin and fibronectin distribution and density.
  • Flow cytometry to analyze thymocyte subpopulations and receptor expression.
  • Quantitative analysis of chemokine (CCL25, CXCL12) and receptor (CCR9, CXCR4) expression.
  • In vitro migration assays for thymocytes.

Main Results:

  • Diabetic mice exhibited significant thymic atrophy and altered histological patterns.
  • Laminin distribution and density were significantly changed in the diabetic thymus.
  • Expression of fibronectin and laminin receptors decreased in diabetic mice.
  • A marked decrease in CCL25, CXCL12, and CCR9 expression was observed, while CXCR4 remained unchanged.
  • In vitro thymocyte migration capacity showed no significant difference between groups.

Conclusions:

  • Diabetes induces substantial alterations in the thymic microenvironment.
  • These changes may impact T cell development and maturation in diabetic individuals.
  • The findings provide insights into the endocrine influences on lymphoid organs and T cell biology.